compounding-hrt-solution-for
Compounding HRT Solutions for Progesterone Cream Therapy Patients
Educational information about compounded hormone therapy considerations for progesterone cream therapy patients, including discussion of commonly prescribed medications and clinical context.
Not medical advice. Speak with a healthcare professional before using any medication.
Reviewed by:
Updated Feb, 15
Not sure what’s worth trying?
At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsCompounding HRT Solutions for Progesterone Cream Therapy Patients
DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.
This page provides educational information about progesterone cream therapy and medications typically discussed in its management. Progesterone is a hormone used in various forms as part of hormone replacement therapy, particularly to balance estrogen in women who have a uterus or to support the luteal phase. Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. Clinical decisions about the management of progesterone-related hormone therapy should be made with a qualified clinician.
According to NAMS (The Menopause Society), progesterone therapy plays an important role in endometrial protection for women using systemic estrogen, and the choice of formulation — oral, vaginal, or topical — is individualized based on patient history, tolerability, and clinical factors. Comparing commercially available options with compounded preparations requires discussion with a qualified prescribing clinician who is familiar with the current evidence and the patient's specific circumstances.
Common symptoms of Progesterone Cream Therapy
Learn about common signs of hormonal imbalance and how they may affect overall health and well-being.
Breast tenderness
According to NIH MedlinePlus and NAMS (The Menopause Society), breast tenderness associated with progesterone cream therapy may present as a diffuse, often bilateral sense of fullness and sensitivity that feels sore to touch or under pressure. The discomfort may begin hours to days after application, may fluctuate with dosing changes, and may resemble the soreness typical of the luteal phase of the menstrual cycle. Affected breasts may feel heavy, mildly swollen, or slightly nodular, with discomfort ranging from a dull ache to intermittent sharp twinges; skin appearance is usually normal. Patients experiencing persistent, worsening, or unusual breast changes should seek evaluation from a qualified clinician, as new or severe breast symptoms may indicate a condition requiring further assessment.
Mood changes
According to NIH MedlinePlus and NAMS (The Menopause Society), mood changes associated with progesterone cream therapy may present as increased irritability, anxiety, low mood, or emotional sensitivity, reflecting the neuroactive properties of progesterone metabolites — particularly allopregnanolone — on GABA receptors in the brain. These effects may vary in intensity depending on dose, individual sensitivity, and concurrent hormonal influences. According to the Endocrine Society Clinical Practice Guideline, mood-related symptoms during hormone therapy warrant clinical evaluation to distinguish hormone-related effects from other underlying conditions. Patients experiencing significant mood disturbances, persistent low mood, or thoughts of self-harm should seek prompt evaluation from a qualified clinician.
Bloating
According to NIH MedlinePlus and NAMS (The Menopause Society), bloating during progesterone cream therapy may present as a sense of abdominal fullness and visible distension, often accompanied by trapped gas and mild cramping. The sensation may feel like pressure or tightness across the lower abdomen and may fluctuate with dosing or menstrual timing. Progesterone's relaxing effect on smooth muscle may contribute to slowed gastrointestinal motility, increased fluid retention, and worsened symptoms later in the day. Patients experiencing severe abdominal pain, persistent distension, or symptoms that do not improve with dose adjustment should seek evaluation from a qualified clinician, as these symptoms may indicate an unrelated gastrointestinal condition.
Headaches
According to NIH MedlinePlus and NAMS (The Menopause Society), headaches during progesterone cream therapy may present as a dull, pressure-like, or throbbing pain across the temples or forehead, sometimes accompanied by sensitivity to light or mild nausea. These symptoms may arise from systemic hormone shifts, vascular effects, or individual sensitivity to changes in absorption or dose. Headaches may occur after application or with dose adjustments and may vary in intensity and duration between individuals. Patients experiencing severe, sudden, or worsening headaches — particularly those accompanied by visual changes, neurological symptoms, or vomiting — should seek urgent evaluation from a qualified clinician, as such symptoms may indicate a serious underlying condition.
Contact Us for a Personalized Care Plan
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Compounded Hormone Therapy — Educational Information for Progesterone Cream Therapy
Compounded Hormone Therapy Considerations in Progesterone Cream Therapy — Educational Information
Progesterone cream therapy involves the management of hormone levels and requires diagnosis and ongoing oversight by a qualified clinician. According to NAMS (The Menopause Society) Position Statement on hormone therapy, the appropriate use of progestogen in hormone replacement therapy — including the selection of formulation, dose, and route — should be determined through individualized clinical evaluation that accounts for personal and family medical history, treatment goals, and benefit-risk considerations.
According to the FDA-approved prescribing information for Prometrium, micronized progesterone taken orally is indicated for endometrial protection in non-hysterectomized postmenopausal women receiving estrogen, and for secondary amenorrhea. The prescribing information for Crinone, Endometrin, and Cyclogest similarly describes FDA-approved routes including vaginal gel and vaginal inserts for luteal phase support and assisted reproduction. The Endocrine Society Clinical Practice Guideline on menopause notes that evidence for transdermal and topical progesterone formulations — including creams — is more limited compared to oral and vaginal routes, particularly regarding reliable endometrial protection.
FDA Boxed Warning: According to the FDA-approved prescribing information for Prometrium (and applicable to estrogen-progestogen combinations), systemic hormone therapy carries boxed warnings regarding increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women, as reported in the Women's Health Initiative. Patients and clinicians should review these risks before initiating any hormone therapy.
Compounded progesterone preparations are not reviewed by FDA for safety or effectiveness before dispensing. A prescribing clinician may, at their discretion, consider a compounded formulation in specific clinical circumstances — for example, when a patient has a documented allergy to an ingredient in a commercially available product, or when a non-standard dose or base is required — provided that decision is supported by the patient's clinical presentation and the prescriber's professional judgment. This is a clinical determination that belongs with the prescribing clinician, not the pharmacy.
This page is provided for educational purposes only and does not constitute medical advice or a recommendation for any specific treatment. Patients should discuss all hormone therapy options — including commercially available medications and compounded preparations — with a qualified prescribing clinician who is familiar with current evidence and the patient's individual circumstances.
All brand names and trademarks are the property of their respective owners. References to commercial products are provided for educational and search-reference purposes only. Voshell's Pharmacy does not claim equivalence, substitution, or superiority to any commercial product.
Prescription Medications Discussed in Progesterone Cream Therapy
Individualized compounded HRT therapies aimed at promoting hormonal stability and comprehensive health support.
Prometrium
According to the FDA-approved prescribing information for Prometrium, Prometrium is a micronized progesterone capsule indicated for the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogen tablets, and for use in secondary amenorrhea. The labeling describes that progesterone suppresses endometrial proliferation driven by estrogen and may contribute to changes in sleep architecture and mood through its neuroactive metabolite allopregnanolone. Per the labeling, adverse effects may include dizziness, drowsiness, breast tenderness, and headache; Prometrium contains peanut oil and is contraindicated in patients with peanut allergy. The FDA-approved prescribing information also notes that estrogen plus progestogen therapy carries boxed warnings regarding increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women, as established in the Women's Health Initiative. Any compounded preparation involving progesterone is not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Prometrium is separately regulated, and clinical decisions belong with the prescribing clinician.
Crinone
According to the FDA-approved prescribing information for Crinone, Crinone is a progesterone gel (8%) indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency, and for the treatment of secondary amenorrhea. The labeling describes that Crinone delivers progesterone directly to the vaginal and uterine tissues through a bioadhesive polycarbophil-based gel matrix, providing sustained local release. Per the labeling, adverse effects may include perineal pain, headache, constipation, nausea, and vaginal discharge; patients using Crinone may also experience accumulation of the gel vehicle in the vaginal canal with prolonged use. Any compounded preparation involving progesterone gel is not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Crinone is separately regulated, and clinical decisions belong with the prescribing clinician.
Endometrin
According to the FDA-approved prescribing information for Endometrin, Endometrin is a progesterone vaginal insert (100 mg) indicated to support embryo implantation and early pregnancy by supplementing corpus luteal function as part of an ART treatment program. The labeling describes that Endometrin delivers micronized progesterone locally to the vaginal-cervical environment, providing endometrial support through direct tissue absorption. Per the labeling, adverse effects may include vaginal spotting or bleeding, vaginal discharge, pelvic pain, and bloating; systemic levels are generally lower compared to oral routes. Any compounded preparation involving progesterone inserts is not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Endometrin is separately regulated, and clinical decisions belong with the prescribing clinician.
Cyclogest
According to the FDA-approved prescribing information for Cyclogest, Cyclogest is a progesterone pessary (100 mg and 200 mg) indicated for the management of premenstrual syndrome and for luteal phase support, including in assisted reproduction and as endometrial protection during estrogen therapy. The labeling describes that Cyclogest delivers micronized progesterone through vaginal or rectal mucosal absorption, providing measurable serum progesterone levels. Per the labeling, adverse effects may include local irritation, bloating, breast tenderness, and mood changes; absorption and serum levels may vary with route of administration. Any compounded preparation involving progesterone suppositories is not reviewed by FDA for safety or effectiveness before dispensing. Commercially available Cyclogest is separately regulated, and clinical decisions belong with the prescribing clinician.
Contact Us for a Personalized Care Plan
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Medications Made Just for You
Voshell's Pharmacy Medications
Explore Voshells Pharmacy medications, including uses, availability, and trusted guidance to help you manage your health safely and effectively.
